Jan Mašek

Jan Ma is a seasoned professional with extensive experience in commercial strategy and planning within the biotechnology and pharmaceutical sectors. Currently serving as the Head of Commercial Strategy & Planning at Pliant Therapeutics since September 2020, Jan has previously held roles such as Associate Director at Lyell Immunopharma, where expertise in market analytics and competitive intelligence supported cell therapy portfolio strategy. Jan's background includes positions at Mitra Biotech and Genentech, focusing on commercial launch strategies, oncology market access, and product strategy. Additionally, experience includes work with Roche on expanding cancer care access, technical operations at Novartis, and product development at Procter & Gamble. Jan holds an MBA from MIT Sloan School of Management and advanced degrees in Bioengineering and Biomedical Engineering from Cornell University.